-The Telegraph New Delhi: Countries negotiating a global declaration on tuberculosis are under pressure to give up their rights to use existing provisions in world trade laws to provide affordable second-line and new anti-TB drugs to their populations, an international humanitarian agency said on Friday. Medecins Sans Frontieres said the US was "exerting extreme pressure" on other negotiators by refusing to sign the declaration if it retained text that "recognises the importance...

-The Telegraph New Delhi: Patients' rights advocates in India on Tuesday filed two oppositions in the Indian patent office, challenging patent claims by the US pharmaceutical company Gilead Sciences for its medicines sofosbuvir and velpatasvir, used to treat hepatitis-C infections. The oppositions filed by the Delhi Network of Positive People (DNP+) challenge Gilead's patent applications for the tablet formulations of the fixed dose combination of sofosbuvir and velpatasvir and a new form...

-The Hindu Business Line The Ayushman Bharat programme must aim to reverse poverty caused by healthcare expenses The state of India’s healthcare system is somewhat dichotomous — the country is a global supplier of life-saving, affordable and good quality generic medicines, yet lakhs of families are driven into poverty because they are forced to spend much of their earnings and savings on medications to treat chronic and life-threatening diseases. The poor, particularly,...

-The Indian Express The state Cabinet on Tuesday ratified the draft medical policy, which, among others, proposes a standard treatment guideline covering all hospitals to ensure 'rationale, effective and affordable treatment'. Thiruvananthapuram: In an effort to ensure that all children below the age of five are immunised, the Left Front government in Kerala has made vaccination certificate mandatory for admission to class-I from the next academic session. Health Minister K K Shailaja...

-The Hindu Business Line Public procurement at a negotiated price is a better option. Price curbs deter producers and don’t check pharmacy margins The Government’s attempt to keep the prices of essential medicines affordable and curb the extraordinary returns earned by private healthcare providers through price controls has started an inexorable process whose end does not seem in sight. Will these moves eventually be counter-productive? First came the move to extend the scope...